Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Cultivated Biosciences SA

History from 20 Dec 2021

UID
CHE-204.378.349
Legal form
AG
Canton
ZH
Founded
20 Dec 2021
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 281k
70k141k211k281k25 Jul 2022 · CHF 136k26 Jan 2024 · CHF 199k27 Apr 2026 · CHF 281k2023202420252026
  • bisher 1'000'000 Namenaktien zu CHF 0.10
  • all shares
  • shares
  • Vorzugsaktien Pre-Seed
  • Vorzugsaktien Seed
  • Vorzugsaktien Late Seed

Record

  1. Company formed

    Founded 20 Dec 2021

    SHAB HR01-1005368586 ↗
  2. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    100’000 → 136’047.50
    Shares
    1’283’647 → 1’360’475
    New shares, % of post-step shares
    5.6% (76’828 new)

    Ordentliche Kapitalerhöhung: Aktienkapital neu: CHF 136'047.50 (bisher CHF 100'000). Liberierung neu: CHF 86'047.50 (bisher CHF 50'000). Aktien neu: 1'360'475 Namenaktien zu CHF 0.10 (bisher 1'000'000 Namenaktien zu CHF 0.10). Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005528149 ↗
  3. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    136’047.50 → 199’083.90
    Shares
    2’698’074 → 3’351’314
    New shares, % of post-step shares
    19.5% (653’240 new)
    Share classes
    1’000’000 × CHF 0.10 Stammaktien · 360’475 × CHF 0.10 Vorzugsaktien Pre-Seed · 630’364 × CHF 0.10 Vorzugsaktien Seed · 1’360’475 × CHF 0.10

    Aktienkapital neu: CHF 199'083.90 (bisher CHF 136'047.50). Liberierung neu: CHF 149'083.90 (bisher CHF 86'047.50). Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 (Stammaktien), 360'475 Namenaktien zu CHF 0.10 (Vorzugsaktien Pre-Seed), 630'364 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed) (bisher 1'360'475 Namenaktien zu CHF 0.10). Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005945133 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    199’083.90 → 281’247.50
    Shares
    1’990’839 → 2’812’475
    New shares, % of post-step shares
    29.2% (821’636 new)
    Share classes
    1’000’000 × CHF 0.10 · 360’475 × CHF 0.10 Vorzugsaktien Pre-Seed · 630’364 × CHF 0.10 Vorzugsaktien Seed · 821’636 × CHF 0.10 Vorzugsaktien Late Seed

    Aktienkapital neu: CHF 281'247.50 [bisher: CHF 199'083.90]. Liberierung Aktienkapital neu: CHF 231'247.50 [bisher: CHF 149'083.90]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10, 360'475 Namenaktien zu CHF 0.10 (Vorzugsaktien Pre-Seed), 630'364 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed) und 821'636 Namenaktien zu CHF 0.10 (Vorzugsaktien Late Seed) [bisher: 1'000'000 Namenaktien zu CHF 0.10, 360'475 Namenaktien zu CHF 0.10 (Vorzugsaktien Pre-Seed) und 630'364 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.96 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006634955 ↗
  5. Name changed

    Cultivated Biosciences SA → Cosaic AG

    SHAB HR02-1006634955 ↗

Published by 8 Oct 2026